Cerebral Small Vessel Disease burden: An independent biomarker for anomia treatment responsiveness in chronic stroke patients with aphasia

CONCLUSIONS: cSVD, a marker of brain reserve and a robust risk factor for post-stroke dementia, may be used as a biomarker for distinguishing patients that are more likely to respond to anomia therapy from those that are less likely to do so and for individualizing treatment parameters (e.g., targeting both linguistic and nonlinguistic cognition in severe cSVD).PMID:37290492 | DOI:10.1016/j.apmr.2023.05.008
Source: Health Physics - Category: Physics Authors: Source Type: research